Genetic Assessment of the Patients With Metabolic Syndrome (GENMetS)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01268696|
Recruitment Status : Unknown
Verified December 2010 by Medical Universtity of Lodz.
Recruitment status was: Active, not recruiting
First Posted : December 31, 2010
Last Update Posted : July 22, 2011
Metabolic syndrome is a combination of medical disorders that increase the risk of developing cardiovascular disease and diabetes. The exact mechanisms of the complex pathways of metabolic syndrome are not yet completely known. The pathophysiology is extremely complex and has been only partially elucidated. Most patients are older, obese, sedentary, and have a degree of insulin resistance. Stress can also be a contributing factor. The most important factors are:
weight, genetics, aging, sedentary lifestyle,excess caloric intake. In our study we will assess the role of some polymorphisms in the pathology of metabolic syndrome.
|Condition or disease|
|Study Type :||Observational|
|Estimated Enrollment :||300 participants|
|Official Title:||Genetic Assessment of the Patients With Metabolic Syndrome in Polish Population|
|Study Start Date :||December 2010|
|Estimated Primary Completion Date :||August 2011|
|Estimated Study Completion Date :||January 2015|
Patients with metabolic syndrome
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01268696
|Department of medical biotechnology Medical University of Lodz|
|Study Chair:||Tadeusz Pietrucha, prof.||Department of medical biotechnology|